Sort
78,016 grants matching “breast cancer”
Scalable Clinical Decision Support for Individualized Cancer Risk Management
$745,481Guilherme Del Fiol · University Of Utah · U24 · FY2020 · CA
Ultrasound imaging and local drug delivery in tumors
$745,283Katherine W Ferrara · University Of California At Davis · R01 · FY2010 · CA
Leveraging DNA damage repair pathways as therapeutic targets in womens cancers
$745,273Jung-Min Lee · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
An Open-Labeled, Single Arm Phase 2 Efficacy and Safety Study of REM-001 Photodynamic Therapy (PDT) for Treatment of Cutaneous Metastatic Breast Cancer (CMBC)
$745,259Dennis Brown · Kintara Therapeutics, Inc. · R44 · FY2024 · CA
Ultrasound imaging and local drug delivery in tumors
$745,185Katherine W Ferrara · University Of California At Davis · R01 · FY2009 · CA
Nanoparticle-based targeted codelivery of siRNA and taxane to treat drug-resistant HER2+ breast cancer
$745,151Worapol Ngamcherdtrakul · Pdx Pharmaceuticals, Inc. · R44 · FY2018 · CA
Identifying Diagnostic Markers for Cervical, Breast, and Prostate Cancer
$745,146Thomas Ried · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Columbus NCORP RFA-CA-18-016
$745,063Timothy David Moore · Columbus Community Clinical Oncology Prg · UG1 · FY2019 · CA
NRG ONCOLOGY NETWORK GROUP OPERATIONS CENTER
$745,015Norman Wolmark · Nrg Oncology Foundation, Inc. · U10 · FY2018 · CA
Community Clinical Oncology Program
$744,967Norman Wolmark · Nsabp Foundation, Inc. · U10 · FY2006 · CA
Onco-primary care networking to support TEAM-based care - the ONE TEAM Study
$744,941Kevin Charles Oeffinger · Duke University · R01 · FY2023 · CA
Physiological and pathological functions of E3 ubiquitin ligases Smurfs
$744,878Ying Zhang · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
PROMINENT - Stanford
$744,867Emma Lundberg · Stanford University · OT2 · FY2023 · CA
Targeting Slc16a/Mct Lactate Transporters in Cancer Therapeutics
$744,805John L. Cleveland · Scripps Florida · R01 · FY2013 · CA
Prospective Trial of a Linguistically and Culturally Appropriate Mainstreaming Model for Hereditary Cancer Multigene Panel Testing Among Diverse Cancer Patients
$744,686Jada Gabrielle Hamilton · Sloan-Kettering Inst Can Research · U01 · FY2023 · CA
Translational Geroscience Network
$744,685Robert John Pignolo · Mayo Clinic Rochester · R33 · FY2024 · AG
Using Genomics to Reduce Breast Cancer Disparities in the African Diaspora
$744,499Olufunmilayo I Olopade · University Of Chicago · U01 · FY2015 · CA
Clinical Trial of Vitamin D3 to Reduce Cancer Risk in Postmenopausal Women
$744,389Joan M Lappe · Creighton University · R01 · FY2012 · CA
Single-cell to population-based analysis of the microRNA-p53 interaction network
$744,324Lan Ma · University Of Texas At Dallas · · FY2014 · MPS
Epigenetic Regulation of Normal and Pathologic CTCF Functions by BORIS
$744,264Victor Lobanenkov · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Fluorescence-based sequence-specific imaging of RNA modifications
$744,234Ling Tian · Mediomics, Llc · R44 · FY2025 · GM
Cancer Pain Management: A Technology-Based Intervention for Asian American Breast Cancer Survivors
$744,214Eun-Ok Im · Emory University · R61 · FY2022 · CA
Decreasing Cardiometabolic Risk in Survivors of Childhood Cancer: Survivors engaged in Time-Restricted EatiNG after THerapy (STRENGTH)
$744,198Danielle Friedman · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA
Mammary carcinogenesis: pubertal and adult effects of high fat diet+oxybenzone
$744,137Richard C Schwartz · Michigan State University · U01 · FY2019 · ES
Immune reconstitution following autologous and allogeneic stem cell transplant
$744,123Frances Hakim · Division Of Basic Sciences - Nci · ZIC · FY2011 · CA